News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Maria Fernandez Abad

Articles by Maria Fernandez Abad

20 Impact of Ribociclib Dose Reduction on Efficacy in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast

ByRadhika Appaya,Erika P. Hamilton, MD,Thomas Decker,Hope S. Rugo, MD,Maria Fernandez Abad,Kevin Kalinsky, MD, MS,Qiang Liu,Mariya Rozenblit, MD,Barbara Radecka,Seock-Ah Im,Frances Visco,Alejandro Perez,Yogesh Chattar,Murat Akdere,Vaidyanathan Ganapathy,Sorcha Waters,Joyce O’Shaughnessy, MD

June 27th 2025

Latest Updated Articles

Trending on CancerNetwork

Spotlighting the Top 10 FDA Oncology Approvals in 2025

Ivosidenib Combo Shows Preliminary Activity in IDH1-Mutated AML

Zovegalisib Combo Confers Efficacy Benefit in PIK3CA-Mutated Breast Cancer

What’s New in Hematology/Oncology? Discussing the 2025 ASH Annual Meeting

A Look Back on the Top 10 Oncology Interviews in 2025